Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC

Journal of Pharmaceutical and Biomedical Analysis

Volumn 29, Issue 1-2, 2002, Pages 17-33

  Robatel, C ^a   Buclin, T ^a   Eckert, P ^a,b   Schaller, M D ^a   Biollaz, J ^a   Decosterd, L A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Hopital de Sion   (Switzerland)

Author keywords

Carbapenem stability; Continuous haemodiafiltration; CVVHDF; Meropenem; Solid phase extraction

Indexed keywords

DRUG METABOLITE; MEROPENEM; TETRABUTYLAMMONIUM; UK 1A; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD FILTRATION; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STABILITY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PH; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLID PHASE EXTRACTION; TERMINALLY ILL PATIENT;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; REPRODUCIBILITY OF RESULTS; THIENAMYCINS;

EID: 0037142269     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00022-5     Document Type: Article

References (32)